Use of LC-MS for the quality control of radiopharmaceuticals: example of [(18)F]ML10.

J Labelled Comp Radiopharm

GSK-Clinical Imaging Centre, Molecular Imaging, Du Cane Road, Hammersmith Hospital, London, W12 0NN, UK.

Published: May 2013

[(18)F]ML10 is a promising novel low molecular weight positron emission tomography probe for apoptosis. As part of the quality control to support clinical studies for cancer therapy monitoring in the GSK Clinical Imaging Centre, a simple and sensitive liquid chromatography mass spectrometry method has been developed and validated for the quantification of total ML10 and impurity content in the final product. Chromatographic separation of ML10 and its radiolabelling precursor and impurities was achieved. Mass curves were constructed from a concentration range of ML10 and known impurities and were linear. Quantification was achieved by comparison of the area under the curve for ML10 content (m/z = 205) and the mass curve. The method was validated over a concentration range of 0.1-1 µg/ml.

Download full-text PDF

Source
http://dx.doi.org/10.1002/jlcr.3023DOI Listing

Publication Analysis

Top Keywords

quality control
8
concentration range
8
lc-ms quality
4
control radiopharmaceuticals
4
radiopharmaceuticals example
4
example [18f]ml10
4
[18f]ml10 [18f]ml10
4
[18f]ml10 promising
4
promising novel
4
novel low
4

Similar Publications

Unlabelled: Cancer cachexia, a multifactorial condition resulting in muscle and adipose tissue wasting, reduces the quality of life of many people with cancer. Despite decades of research, therapeutic options for cancer cachexia remain limited. Cachexia is highly prevalent in people with pancreatic ductal adenocarcinoma (PDAC), and many animal models of pancreatic cancer are used to understand mechanisms underlying cachexia.

View Article and Find Full Text PDF

An Assay System for Plate-based Detection of Endogenous Peptide:-glycanase/NGLY1 Activity Using A Fluorescence-based Probe.

Bio Protoc

January 2025

Glycometabolic Biochemistry Laboratory, RIKEN Cluster for Pioneering Research, Riken, 2-1 Hirosawa, Wako Saitama, Japan.

Cytosolic peptide:-glycanase (PNGase/NGLY1 in mammals), an amidase classified under EC:3.5.1.

View Article and Find Full Text PDF

The First Case of Detection and Infection Control in a Pediatric Bone Marrow Transplant Child Patient in Guangxi, China.

Infect Drug Resist

January 2025

Department of Laboratory Medicine, Shanghai East Hospital, School of Life Sciences and Technology, Tongji University, Shanghai, People's Republic of China.

is an emerging yeast species and an opportunistic pathogen. Due to its multi-drug resistance and ability to colonize and transmit, it poses a significant risk for outbreaks in medical institutions. In this study, we report the first case of detected in a pediatric bone marrow transplant child patient in Guangxi, China.

View Article and Find Full Text PDF

The objective of this study was to investigate the effect of the () SS18-50 (an isolate with favorable probiotic properties following space traveling) on dextran sulfate sodium (DSS)-induced colitis in mice. Male ICR mice were randomly assigned to one of six groups: a control group, a model group, and four intervention groups comprising the isolate (SS18-50-L and SS18-50-H) and the wild type (GS18-L and GS18-H) strains. The model group and the intervention groups were administered a 3.

View Article and Find Full Text PDF

, a special economic aquaculture species in China, is valued highly for its medicinal and nutritional benefits. However, the muscle of farmed exhibits a strong off-flavor, resulting in poor flavor quality. To enhance the flavor quality of the meat, this study examined the volatile compounds in muscle by establishing identification methods for these volatile odor compounds and comparing the differences between the two aquaculture modes.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!